Speech-Language Pathologists in North Attleboro, MA Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Jacqueline Belham, MS CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 Dodge Ave, North Attleboro, MA 02760 Phone: 508-643-0964 |
Tess Antonitis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 238 S Washington St, North Attleboro, MA 02760 Phone: 508-251-9774 |
Jillian Wesh Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Laurie Ln, North Attleboro, MA 02760 Phone: 607-292-7018 |
Erica L Dunn, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Harris Dr, North Attleboro, MA 02760 Phone: 508-838-9778 |
News Archive
Origami-inspired artificial muscles can lift 1,000 times their weight
Soft robots that are incredibly light and foldable and can lift weights that are over 1,000 times their own weight and these are also cheap and easy to make costing less than a dollar in making charges.
Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs
Administering antibiotics to adults hospitalized with an asthma exacerbation without any documented indication of lung infection appears to lengthen hospital stay, increase cost and result in increased risk for antibiotic-related diarrhea, according to new research presented at the ATS 2018 International Conference.
Study observes increased breadth of SARS-CoV-2 antibody neutralization acquired over one year
A new paper in the journal Nature offers a reassuring answer, showing that convalescent COVID-19 patients, some of whom had received vaccination as well, retain antiviral antibodies and neutralizing activity, as well as memory B cells, for up to 6-12 months from infection.
Today's selection of opeds: Cutting health costs
Many commentators have treated the Senate Finance bill as the likely template for any final legislation because it may be more palatable to conservative Democrats, and deficit hawks, in both houses.
Oramed reports positive results from ORMD-0801 pharmacokinetic study in type 1 diabetes patients
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today successful results in a clinical trial testing the pharmacokinetic dose response of its oral insulin capsule (ORMD-0801) in type 1 diabetes patients.
› Verified 2 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Podiatrists